WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 5 fonti

GLP-1 use hits record high as Medicare opens access to weight-loss drugs

The share of U.S. adults taking GLP-1 medications to lose weight has reached a record 11%.

Raccontata daforbes.commedpagetoday.comgizmodo.comcnbc.commedicalxpress.com

Confronto fonti

5 prospettive sulla stessa storia
AI · summaries
medicalxpress.comStai leggendo4 g fa

GLP-1 use hits record high as Medicare opens access to weight-loss drugs

The share of U.S. adults taking GLP-1 medications to lose weight has reached a record 11%.

originale
forbes.com7 g fa

U.S. Obesity Rate Drops As GLP-1 Usage Grows

A new Gallup poll found about 11% of Americans were taking a GLP-1 medication for weight loss.

Leggi questa versione → originale
gizmodo.com6 g fa

11% of Americans Are Currently Taking a GLP-1 Weight Loss Drug Like Wegovy

15% of Americans have ever taken the drugs, up from 6% in 2024.

Leggi questa versione → originale
cnbc.com6 g fa

Healthy Returns: Employers aren't expanding coverage of GLP-1 obesity drugs – many are finding ways around it

Around 36% of employers said they provide coverage of GLP-1s for both diabetes and weight loss, the same as 2025 and up from 34% in 2024, the survey said.

Leggi questa versione → originale
medpagetoday.com7 g fa

Record High GLP-1 Use; Intense Interval Exercise; Endometriosis and Androgens

News and commentary from the endocrinology world

Leggi questa versione → originale

Timeline cronologica

  1. martedì 7 luglio 2026·forbes.com

    U.S. Obesity Rate Drops As GLP-1 Usage Grows

    A new Gallup poll found about 11% of Americans were taking a GLP-1 medication for weight loss.

  2. martedì 7 luglio 2026·medpagetoday.com

    Record High GLP-1 Use; Intense Interval Exercise; Endometriosis and Androgens

    News and commentary from the endocrinology world

  3. mercoledì 8 luglio 2026·gizmodo.com

    11% of Americans Are Currently Taking a GLP-1 Weight Loss Drug Like Wegovy

    15% of Americans have ever taken the drugs, up from 6% in 2024.

  4. mercoledì 8 luglio 2026·cnbc.com

    Healthy Returns: Employers aren't expanding coverage of GLP-1 obesity drugs – many are finding ways around it

    Around 36% of employers said they provide coverage of GLP-1s for both diabetes and weight loss, the same as 2025 and up from 34% in 2024, the survey said.

  5. giovedì 9 luglio 2026·medicalxpress.com

    GLP-1 use hits record high as Medicare opens access to weight-loss drugs

    The share of U.S. adults taking GLP-1 medications to lose weight has reached a record 11%.